000			02076 a2200589 4500
005			20250517120959.0
264		0	_c20170808
008			201708s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2016.10.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aDu, Jipei
245	0	0	_aBAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB. _h[electronic resource]
260			_bCancer letters _c12 2016
300			_a145-153 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aApoptosis Regulatory Proteins _xmetabolism
650	0	4	_aColonic Neoplasms _xdrug therapy
650	0	4	_aDrug Synergism
650	0	4	_aHCT116 Cells
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aMutation
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aProto-Oncogene Proteins p21(ras) _xgenetics
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aReceptors, TNF-Related Apoptosis-Inducing Ligand _xdrug effects
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTNF-Related Apoptosis-Inducing Ligand _xpharmacology
650	0	4	_aTime Factors
650	0	4	_aTransfection
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
650	0	4	_aUp-Regulation
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aWang, Yufang
700	1		_aChen, Degao
700	1		_aJi, Guangyu
700	1		_aMa, Qizhao
700	1		_aLiao, Shiping
700	1		_aZheng, Yanjiang
700	1		_aZhang, Ji
700	1		_aHou, Yiping
773	0		_tCancer letters _gvol. 383 _gno. 2 _gp. 145-153
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2016.10.002 _zAvailable from publisher's website
999			_c26499134 _d26499134